Tango Therapeutics
This role shapes and executes medical strategy supporting product life-cycle management, including registration and launch activities, evidence generation, external expert engagement planning, and patient advocacy partnerships. It serves as a key strategic partner across clinical development, medical information, HEOR/RWE, commercial, market access, regulatory, and field medical to ensure evidence addresses the needs of healthcare professionals, patients, patient advocacy groups, and payers through late-stage development and launch.
Key Responsibilities
- • Lead development and execution of integrated medical affairs plans across oncology programs
- • Lead medical launch-readiness planning, including pre-launch engagement objectives, resource planning, medical education planning, and integration with registrational and post-approval evidence plans
- • Translate clinical development objectives into evidence generation and stakeholder engagement strategies
- • Develop and maintain routine medical plans aligned with corporate objectives
- • Provide scientific leadership, directing medical affairs team members supporting late-stage development, and partnering with Field Medical to translate medical strategy into engagement objectives, resource plans, tactics, and listening priorities that MSLs execute through scientific exchange
- • Ensure scientific consistency across programs and therapeutic areas
- • Define engagement planning objectives, resource plans, tactics, and insight-listening priorities for advisory boards, congress strategy, and external expert engagement, with scientific exchange executed by Field Medical MSLs
- • Lead the Medical Affairs evidence-generation strategy through late-stage development and launch
- • Prioritize evidence gaps and develop plans to address scientific and clinical questions arising from late-stage and registrational studies
- • Oversee real-world evidence, outcomes research, and post-approval evidence planning
- • Provide medical input to HEOR and RWE strategies supporting value demonstration, in partnership with the HEOR partners
- • Collaborate with Market Access and Commercial teams to generate evidence relevant to payers and healthcare systems
- • Guide protocol development and data interpretation
- • Develop governance and strategy for investigator-sponsored studies
- • Evaluate research proposals and prioritize the IIS portfolio against late-stage evidence needs
- • Manage external scientific collaborations and academic partnerships
- • Ensure alignment between IIS investments and organizational objectives
- • Build and maintain relationships with patient advocacy organizations, incorporate patient perspectives into medical strategy and evidence planning, and ensure all engagement complies with applicable legal and compliance requirements
- • Partner with Clinical Development to support lifecycle evidence planning
- • Collaborate with Biomarker and Diagnostic teams on precision medicine strategies
- • Work closely with Medical Information, Scientific Communications, and Field Medical teams to ensure coordinated execution, including feeding field insights back into engagement planning
- • Support medical review and governance activities
- • Ensure compliance with all legal, regulatory, and ethical requirements
- • Contribute to SOP development and medical affairs operating procedures
Required
- • MD, PharmD, or PhD in a life sciences discipline; MD preferred
- • 12+ years pharmaceutical/biotech experience
- • 7+ years within oncology Medical Affairs
- • 4+ years of experience in Medical Affairs strategic roles
- • Demonstrated success leading cross-functional initiatives
Preferred
- • Experience supporting registration-enabling or launch-stage oncology products
- • Strong background in HEOR, RWE, or post-marketing evidence generation
- • Experience partnering and leading in cross-matrix teams, and engaging patient advocacy organizations
- • Precision oncology and biomarker experience
- • Small biotechnology company experience
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer.
This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
Tango’s labs offices are located at 201 Brookline Avenue, in the vibrant Fenway area of Boston, Massachusetts.
Summary
Tango Therapeutics is seeking an experienced Senior Director, Medical Affairs Strategy, Oncology. Reporting to the Executive Director of Medical Affairs, this individual will shape and execute the medical strategy supporting product life-cycle management including registration and launch activities, evidence generation, external expert engagement planning, and patient advocacy partnerships.
The role will serve as a key strategic partner to Clinical Development, Clinical Operations, Medical Information, Scientific Communications, HEOR/RWE, Biomarkers/Diagnostics, Commercial, Market Access, Regulatory, Safety, Legal, Compliance, and Field Medical to ensure the evidence generated addresses the needs of healthcare professionals, patients, patient advocacy groups, and payers through late-stage development and launch.
Your Role
Medical Affairs Strategy
- Lead development and execution of integrated medical affairs plans across oncology programs
- Lead medical launch-readiness planning, including pre-launch engagement objectives, resource planning, medical education planning, and integration with registrational and post-approval evidence plans
- Translate clinical development objectives into evidence generation and stakeholder engagement strategies
- Develop and maintain routine medical plans aligned with corporate objectives
- Provide scientific leadership, directing medical affairs team members supporting late-stage development, and partnering with Field Medical to translate medical strategy into engagement objectives, resource plans, tactics, and listening priorities that MSLs execute through scientific exchange
- Ensure scientific consistency across programs and therapeutic areas
- Define engagement planning objectives, resource plans, tactics, and insight-listening priorities for advisory boards, congress strategy, and external expert engagement, with scientific exchange executed by Field Medical MSLs
- Lead the Medical Affairs evidence-generation strategy through late-stage development and launch
- Prioritize evidence gaps and develop plans to address scientific and clinical questions arising from late-stage and registrational studies
- Oversee real-world evidence, outcomes research, and post-approval evidence planning
- Provide medical input to HEOR and RWE strategies supporting value demonstration, in partnership with the HEOR partners
- Collaborate with Market Access and Commercial teams to generate evidence relevant to payers and healthcare systems
- Guide protocol development and data interpretation
- Develop governance and strategy for investigator-sponsored studies
- Evaluate research proposals and prioritize the IIS portfolio against late-stage evidence needs
- Manage external scientific collaborations and academic partnerships
- Ensure alignment between IIS investments and organizational objectives
- Build and maintain relationships with patient advocacy organizations, incorporate patient perspectives into medical strategy and evidence planning, and ensure all engagement complies with applicable legal and compliance requirements
- Partner with Clinical Development to support lifecycle evidence planning
- Collaborate with Biomarker and Diagnostic teams on precision medicine strategies
- Work closely with Medical Information, Scientific Communications, and Field Medical teams to ensure coordinated execution, including feeding field insights back into engagement planning
- Support medical review and governance activities
- Ensure compliance with all legal, regulatory, and ethical requirements
- Contribute to SOP development and medical affairs operating procedures
What You Bring:
- MD, PharmD, or PhD in a life sciences discipline; MD preferred
- 12+ years pharmaceutical/biotech experience
- 7+ years within oncology Medical Affairs
- 4+ years of experience in Medical Affairs strategic roles
- Demonstrated success leading cross-functional initiatives
- Experience supporting registration-enabling or launch-stage oncology products
- Strong background in HEOR, RWE, or post-marketing evidence generation
- Experience partnering and leading in cross-matrix teams, and engaging patient advocacy organizations
- Precision oncology and biomarker experience
- Small biotechnology company experience
Salary range
$34,000—$380,000 USD
Keep track of your job search
Save personal notes for each job to track your thoughts, application status, and follow-ups.
Try for freeUpload your resume
Sign up to upload your resume and get AI-powered customization for job applications.
Sign up freePractice your interview
Get AI-powered mock interviews tailored to this Senior Director, Medical Affairs Strategy, Oncology role. Upload your resume and practice with real-time voice feedback.
Sign up to practice